Biogen’s Plea To Medicare: Just Cover The Aduhelm Clinical Trial Population

 
• By Cathy Kelly
  
Medicare Is US Gatekeeper For Alzheimer's Drug Access • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers